Home

ABOUT

Editorial

PRESS RELEASES

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR

SUBSCRIBE

Market Reports

FDA

Executives

Funding

Non Profits

Hospitals

Acquisitions

Health

Biotechnology News Magazine

HomeMiMedx

MiMedx

New Study Shows Advanced Treatment (AT) for Management of LEDUs Among Medicare Beneficiaries is Associated with Significant Reductions in Major & Minor Amputation, Emergency Department Use, & Hospital Readmissions vs. LEDUs Managed Without AT (NAT)

“The data derived from this study are important for a number of reasons,” noted Dr. David G. Armstrong, Professor of Surgery and Director of the Southwestern Academic Limb Salvage Alliance (SALSA) at the Keck School of Medicine of the University of Southern California. Read more.

MIMEDX Receives Regulatory Approval to Commercialize EPIFIX® in Japan

Availability of EPIFIX allografts expected early 2022.

EpiCord Expandable Placental Allograft Is Launched by MiMedx

EpiCord Expandable Placental Allograft covers up to twice the surface area once expanded.

By using this website you agree to accept Medical Device News Magazine Privacy Policy